This topic contains a solution. Click here to go to the answer

Author Question: Patients with renal disease are at risk for developing megaloblastic anemia because of: a. ... (Read 31 times)

V@ndy87

  • Hero Member
  • *****
  • Posts: 571
Patients with renal disease are at risk for developing megaloblastic anemia because of:
 
  a. Decreased EPO production and utilization
  b. Increased NADPH production
  c. Folate deficiency
  d. Acute blood loss

Question 2

Which of the following tests would help differentiate TEC from DBA?
 
  a. RBC count and RBC indices
  b. Bone marrow cellularity and M:E ratio
  c. Fetal erythrocyte characteristics
  d. Ham test



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Ddddd

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

Correct Answer: C

Answer to Question 2

Correct Answer: C




Ddddd

  • Sr. Member
  • ****
  • Posts: 334

 

Did you know?

Medication errors are more common among seriously ill patients than with those with minor conditions.

Did you know?

Vital signs (blood pressure, temperature, pulse rate, respiration rate) should be taken before any drug administration. Patients should be informed not to use tobacco or caffeine at least 30 minutes before their appointment.

Did you know?

All adults should have their cholesterol levels checked once every 5 years. During 2009–2010, 69.4% of Americans age 20 and older reported having their cholesterol checked within the last five years.

Did you know?

According to the American College of Allergy, Asthma & Immunology, more than 50 million Americans have some kind of food allergy. Food allergies affect between 4 and 6% of children, and 4% of adults, according to the CDC. The most common food allergies include shellfish, peanuts, walnuts, fish, eggs, milk, and soy.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library